๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Pharmacokinetics and toxicity of continuous infusion amphotericin B in cancer patients

โœ Scribed by Guy G. Chabot; Richard Pazdur; Frederick A. Valeriote; Laurence H. Baker

Publisher
John Wiley and Sons
Year
1989
Tongue
English
Weight
477 KB
Volume
78
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Pharmacokinetics of amphotericin B in ra
Pharmacokinetics of amphotericin B in rats as a function of dose following constant-rate intravenous infusion
โœ Hsiao-Hui Chow; Yuhong Wu; Michael Mayersohn ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 759 KB

## Abstract Amphotericin B (AmB) is widely used for the treatment of systemic mycoses. The current therapeutic regimens for this drug are complex and somewhat empirical, in part because of very limited information about the disposition kinetics of this agent. In this study, we examined the disposit

Subcutaneous recombinant gamma interfero
Subcutaneous recombinant gamma interferon in cancer patients: toxicity, pharmacokinetics, and immunomodulatory effects
โœ John A. Thompson; W. Welby Cox; Catherine G. Lindgren; Carolyn Collins; Kathryn ๐Ÿ“‚ Article ๐Ÿ“… 1987 ๐Ÿ› Springer-Verlag ๐ŸŒ English โš– 750 KB

Recombinant gamma interferon (ry-IFN) was administered s. c. daily to 26 patients with advanced cancer. Patients were assigned to one of six doses: 0.5, 1, 2, 4, 6, or 8 million units (MU)/m 2 per d. The major toxicities were an influenza-like syndrome and fever, seen in all patients. Dose limiting